Whole body bioluminescence imaging indicated that both types of exosome treatments are efficacious in slowing tumor progression, but BP-αCD3-αEGFR-ARC Exos show enhanced anti-tumor activities compared with CD9-CD38/αCD3-αEGFR Exos (Supplementary Fig. 20). Here, CD38 is linked to neoplasm.